Correlation Between Sprint Bioscience and Toleranzia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Toleranzia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Toleranzia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Toleranzia AB, you can compare the effects of market volatilities on Sprint Bioscience and Toleranzia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Toleranzia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Toleranzia.

Diversification Opportunities for Sprint Bioscience and Toleranzia

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sprint and Toleranzia is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Toleranzia AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Toleranzia AB and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Toleranzia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Toleranzia AB has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Toleranzia go up and down completely randomly.

Pair Corralation between Sprint Bioscience and Toleranzia

Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 2.93 times more return on investment than Toleranzia. However, Sprint Bioscience is 2.93 times more volatile than Toleranzia AB. It trades about 0.05 of its potential returns per unit of risk. Toleranzia AB is currently generating about -0.01 per unit of risk. If you would invest  71.00  in Sprint Bioscience AB on November 5, 2024 and sell it today you would earn a total of  85.00  from holding Sprint Bioscience AB or generate 119.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sprint Bioscience AB  vs.  Toleranzia AB

 Performance 
       Timeline  
Sprint Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sprint Bioscience AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Toleranzia AB 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Toleranzia AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Toleranzia unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sprint Bioscience and Toleranzia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sprint Bioscience and Toleranzia

The main advantage of trading using opposite Sprint Bioscience and Toleranzia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Toleranzia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Toleranzia will offset losses from the drop in Toleranzia's long position.
The idea behind Sprint Bioscience AB and Toleranzia AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data